Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo. [Reuters]
Researchers on Wednesday urged governments to delay administering the second dose of Pfizer Inc’s COVID-19 vaccine, which they said had an efficacy of 92.6% after the first dose.